Evidence map›Paper›PMID 40001577›Full record

ArticleBiomolecules2025

Application of Pseudoinfectious Viruses in Transient Gene Expression in Mammalian Cells: Combining Efficient Expression with Regulatory Compliance.

Gulzat Zauatbayeva, Tolganay Kulatay, Bakytkali Ingirbay, Zhanar Shakhmanova, Viktoriya Keyer, Mikhail Zaripov, Maral Zhumabekova, Alexandr V Shustov

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gulzat ZauatbayevaNational Center for Biotechnology, 010000 Astana, Kazakhstan.ORCID 0000-0003-1514-9302
Tolganay KulatayNational Center for Biotechnology, 010000 Astana, Kazakhstan.
Bakytkali IngirbayNational Center for Biotechnology, 010000 Astana, Kazakhstan.
Zhanar ShakhmanovaNational Center for Biotechnology, 010000 Astana, Kazakhstan.
Viktoriya KeyerNational Center for Biotechnology, 010000 Astana, Kazakhstan.
Mikhail ZaripovInstitute of Theoretical and Experimental Biophysics, 142290 Pushchino, Russia.ORCID 0000-0001-5367-8868
Maral ZhumabekovaNational Center for Biotechnology, 010000 Astana, Kazakhstan.
Alexandr V ShustovNational Center for Biotechnology, 010000 Astana, Kazakhstan.ORCID 0000-0001-9880-9382

Funding

Ministry of Education and Science of the Republic of Kazakhstan BR218004/0223 "Improving measures to ensure biological safety in Kazakhstan: counteracting dangerous and especially dangerous infections"
6 · The paper itself

Abstract

Transient gene expression (TGE) is commonly employed for protein production, but its reliance on plasmid transfection makes it challenging to scale up. In this paper, an alternative TGE method is presented, utilizing pseudoinfectious alphavirus as an expression vector. Pseudoinfectious viruses (PIV) and a replicable helper construct were derived from the genome of the Venezuelan equine encephalitis virus. The PIV carries a mutant capsid protein that prevents packaging into infectious particles, while the replicable helper encodes a wild-type capsid protein but lacks other viral structural proteins. Although PIV and the helper cannot independently spread infection, their combination results in increased titers in cell cultures, enabling easier scale-up of producing cultures. The PIV-driven production of a model protein outperforms that of alphavirus replicon vectors or simple plasmid vectors. Another described feature of the expression system is the modification to immobilized metal affinity chromatography (IMAC), allowing purification of His-tagged recombinant proteins from a conditioned medium in the presence of substances that can strip metal from the IMAC columns. The PIV-based expression system allows for the production of milligram quantities of recombinant proteins in static cultures, without the need for complex equipment such as bioreactors, and complies with regulatory requirements due to its distinction from common recombinant viruses.

Indexed as

AlphavirusEncephalitis Virus, Venezuelan EquineGene ExpressionAnimalsCapsid ProteinsGenetic VectorsHEK293 CellsHumansRecombinant ProteinsCapsid ProteinsRecombinant ProteinsalphavirusIMACimmobilized metal affinity chromatographymammalian expressionpseudoinfectious virusreplicontransient gene expressionVenezuelan equine encephalitis virusviral vector

Identifiers

PMID40001577
PMCPMC11852456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.